FATE (FATE) Stock Price & Analysis
FATE (FATE) rose 0.00% to USD 2.41 as of July 25, 2026 at 03:06 UTC, according to Nexqual real-time market data.
FATE last closed at USD 2.41; the session ranged USD 2.4–2.54 on volume of 1,032,727 shares. Market capitalization is —, with a 52-week range of USD 0.91–3.23 (NGM). Source: Nexqual, July 25, 2026 at 03:06 UTC.
Key Statistics (as of July 25, 2026 at 03:06 UTC)
| Price | USD 2.41 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.41 |
| Open | USD 2.41 |
| Day Range | USD 2.4 – 2.54 |
| 52-Week Range | USD 0.91 – 3.23 |
| Volume | 1,032,727 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (FATE)
Nexqual's technical model rates FATE "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:06 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 43.03 (neutral) |
| vs SMA50 | Above (USD 2.38) |
| MACD | 0.08 (positive) |
From FATE's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TWST | Twist Bioscience Corporation | USD 90.27 | ▼ 4.18% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 4.99 | ▼ 3.48% |
| BEAM | Beam Therapeutics Inc. | USD 25.1 | ▼ 5.78% |
| ALLO | Allogene Therapeutics, Inc. | USD 1.74 | ▼ 6.45% |
| CDNA | CareDx, Inc. | USD 37.14 | ▼ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:06 UTC. This page is informational and not investment advice.